|
Jul 23
|
Billionaires Are Loading Up on This Surging Dow Stock. Should You?
|
|
Jul 23
|
Merck & Co., Inc. (NYSE:MRK) is largely controlled by institutional shareholders who own 78% of the company
|
|
Jul 23
|
Merck claims late-stage study success for RSV antibody
|
|
Jul 23
|
Merck Announces Topline Results from Phase 2b/3 Trial of Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus Preventative Monoclonal Antibody for Infants
|
|
Jun 25
|
USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza
|
|
Jun 25
|
ASCO24: MSD’s ADC shows efficacy in lung and breast tumours
|
|
Jun 24
|
Merck (MRK) Increases Despite Market Slip: Here's What You Need to Know
|
|
Jun 24
|
Is Merck & Co., Inc. (MRK) a Strong Buy Right Now?
|
|
Jun 22
|
With 78% ownership of the shares, Merck & Co., Inc. (NYSE:MRK) is heavily dominated by institutional owners
|
|
Jun 21
|
The 30-stock secret: ‘Don’t fight Papa Dow’
|
|
Jun 20
|
Merck Is Partnering With America’s Largest HBCU To Launch a Collaborative Biotechnology Learning Center
|
|
Apr 7
|
10 Best Weight Loss Drug Stocks to Buy Now
|
|
Apr 6
|
The three-year decline in earnings for Merck NYSE:MRK) isn't encouraging, but shareholders are still up 93% over that period
|
|
Apr 5
|
Merck (MRK) Rises Yet Lags Behind Market: Some Facts Worth Knowing
|
|
Apr 4
|
Merck puts KRAS cancer drug competitor to the test
|
|
Apr 4
|
Merck Initiates Phase 3 Clinical Trial of MK-1084, an Investigational Oral KRAS G12C Inhibitor, in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Certain Patients With Metastatic Non-Small Cell Lung Cancer
|
|
Apr 3
|
Merck (MRK) Stock Sinks As Market Gains: What You Should Know
|
|
Apr 3
|
REJOICE-Ovarian01 Phase 2/3 Trial of Raludotatug Deruxtecan Initiated in Patients with Platinum-Resistant Ovarian Cancer
|
|
Apr 1
|
Why Merck (MRK) is a Top Momentum Stock for the Long-Term
|
|
Apr 1
|
Merck to Hold First-Quarter 2024 Sales and Earnings Conference Call April 25
|